Zenflow
Ronald is an experienced executive who has spent 30 years in the medical device industry and has filed over 100 patents. He has brought many implantable devices to market and has exited four companies successfully.
This person is not in any offices
Zenflow
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction. To meet this clinical need, Zenflow has developed the Spring System. The device is designed to be deployed in the urologist's office in a simple, atraumatic procedure. Ongoing clinical trials have shown positive results out to four years after treatment.